Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, NY, USA
Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO, USA
Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, NY, USA
Center for Pharmacogenomics, Washington University School of Medicine, St. Louis, MO, USA
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY, USA
Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, NY, USA
Department of Genetics and Development, College of Physicians and Surgeons of Columbia University, New York, NY, USA
Division of Genetics, Boston Children’s Hospital, Boston, MA, USA
Pfizer BioTherapeutics Research and Development, Center for Integrative Biology and Biotherapeutics, Pearl River, NY, USA
Copyright © 2014 Anne H. O’Donnell, John R. Edwards, Robert A. Rollins, Nathan D. Vander Kraats, Tao Su, Hanina H. Hibshoosh, Timothy H. Bestor et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
O’Donnell, A. , Edwards, J. , Rollins, R. , Kraats, N. , Su, T. , Hibshoosh, H. and Bestor, T. (2014) Methylation Abnormalities in Mammary Carcinoma: The Methylation Suicide Hypothesis.
Journal of Cancer Therapy,
5, 1311-1324. doi:
10.4236/jct.2014.514131.